Cargando…
Case report: an atypical peripapillary uveal melanoma
BACKGROUND: The treatment of uveal melanoma has seen a shift towards eye conserving treatments. Efforts have been made towards the identification of patients at high risk of metastatic disease with the use of prognostic fine needle biopsy, Monosomy 3 a risk factor for metastatic death thought to occ...
Autores principales: | Lim, Li-Anne, Miyamoto, Cristina, Blanco, Paula, Bakalian, Silvin, Burnier, Miguel N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3917623/ https://www.ncbi.nlm.nih.gov/pubmed/24490833 http://dx.doi.org/10.1186/1471-2415-14-13 |
Ejemplares similares
-
Expression of the metastasis suppressor BRMS1 in uveal melanoma
por: Ventura, Bruna V, et al.
Publicado: (2014) -
Current and emerging treatment options for uveal melanoma
por: Pereira, Patricia Rusa, et al.
Publicado: (2013) -
Vascular endothelial growth factor expression and inhibition in uveal melanoma cell lines
por: Logan, Patrick, et al.
Publicado: (2013) -
Evidence for the Role of Blue Light in the Development of Uveal Melanoma
por: Logan, Patrick, et al.
Publicado: (2015) -
Beta‐blockers exert potent anti‐tumor effects in cutaneous and uveal melanoma
por: Bustamante, Prisca, et al.
Publicado: (2019)